EUVIMED · CrossrefZeitschrift
Antiviral Research
ISSN 0166-3542 · Elsevier BV
Neueste Artikel
Small molecules inhibit hepatitis B and D virus infection by binding the small surface antigen
Novel nirmatrelvir-resistance mutations in SARS-CoV-2 Mpro using a yeast screening platform
Divergent functional checkpoints determine epitope-specific ADE outcomes of SARS-CoV-2 entry
Metabolite screening identifies potent antivirals that mitigate Zika virus-induced ocular pathology
Nanobodies targeting the conserved post-fusion six-helix bundle core provide protective effects against SARS-CoV-2 infection and immunopathology
Inarigivir exhibits RIG-I-independent antiviral activity against HBV DNA replication in vitro by inhibiting viral polymerase activity
Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing
Class I capsid assembly modulators induce potent anti-HBV activity through direct viral suppression, innate immune activation and caspase-3-independent clearance of infected hepatocytes
Field-isolate recombinant tick-borne encephalitis viruses define reporter-stability guidelines for antiviral testing in flaviviruses
Application of emerging technologies in the antiviral field
High-yield production of immunogenic PV3 virus-like particle in yeast
Monoclonal antibodies targeting HBsAg as anti-HDV: clinical prospects
Marine phlorotannins block SARS-CoV-2 entry via ACE2 and attenuate pulmonary inflammation in K18-hACE2 transgenic mice
Remdesivir maintains antiviral potency against clinically relevant SARS-CoV-2 Nsp12 substitutions
Identification of 1,2-dihydroquinazolin-2-ones kinase inhibitors as anti-coronavirus agents
4-octyl itaconate inhibits porcine epidemic diarrhea virus replication by modulating the ferroptosis axis and the autophagy pathway
Low level drug resistance linked to cytomegalovirus UL97 and UL27 mutations detected in maribavir clinical trials
A self-adjuvant trivalent T4 bacteriophage nanoparticle vaccine induces broad protective immunity against Orthoebolaviruses
About artificial intelligence adoption in antiviral drug discovery: Thoughts after ICAR 39
LXN exerts antiviral effects by inhibiting the binding of HMGB1 to the viral genome
N70 S/Y155H combined mutation of neuraminidase of avian influenza H9N2 virus confers oseltamivir and zanamivir resistance and pathogenicity to mice
Nucleoside analogs containing an imino-ribitol sugar exhibit a distinctive pattern of interference with RNA synthesis by the Dengue virus polymerase
Intracellular Zn2+ levels regulate susceptibility to hepatitis B virus infection by modulating NTCP-mediated viral entry
Corrigendum to “Construction of a suckling mouse model based on an EV-C96 clinical isolate and its application in drug screening and vaccine development” [Antivir. Res. 254 (2026) 106511]
RNA-dependent RNA polymerase (RdRp): Structure, function, and antiviral targeting in RNA viruses
NF-κB–driven repression of Nrf2 facilitates HSV-1 replication in SH-SY5Y neuroblastoma and HeLa epithelial cells
Unveiling the antiviral mechanism of A4S7: a synthetic antimicrobial peptide targeting dengue and other mosquito-borne enveloped virus infections
The Golgi-resident protein ACBD3 facilitates the interaction between enteroviral 3A proteins and Exportin-1
Molnupiravir, first small molecule therapeutic to demonstrate therapeutic efficacy against Venezuelan equine encephalitis virus in the cynomolgus macaque model
Meeting report: 39th International Conference on Antiviral Research in Prague, Czech Republic, April 27–May 1, 2026
Jahrgänge
2026 · 1282025 · 1832024 · 2142023 · 2142022 · 1592021 · 1522020 · 2232019 · 2242018 · 2442017 · 2752016 · 2342015 · 2132014 · 2362013 · 2682012 · 1992011 · 3732010 · 3652009 · 3462008 · 3052007 · 2992006 · 1602005 · 1162004 · 1592003 · 1172002 · 1072001 · 802000 · 2441999 · 841998 · 641997 · 2561996 · 2541995 · 3571994 · 3331993 · 3721992 · 3181991 · 3001990 · 2371989 · 761988 · 2191987 · 74
EUVIMED